Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 10, 2013, Pages 2331-2337

  Suzuki, Mihoko ^a   Gomi, Fumi ^b   Sawa, Miki ^a   Ueno, Chikako ^a   Nishida, Kohji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SUMITOMO HOSPITAL   (Japan)

Author keywords

Autofluorescence; Branching vascular networks; Indocyanine green angiography; Polypoidal choroidal vasculopathy

Indexed keywords

VASCULOTROPIN INHIBITOR;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; EYE FUNDUS; FEMALE; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHOROID; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; POLYPS; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84890565109     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-013-2336-1     Document Type: Article

References (20)

1. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10(1):1-8
2. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15(2):100-110
3. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115(4):478-485
4. Yannuzzi LA, Nogueira FB, Spaide RF, Guyer DR, Orlock DA, Colombero D, Freund KB (1998) Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol 116(3):382-383
5. Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K (2012) Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy. Br J Ophthalmol 96(3):394-399
6. Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K, Ohtsuka H, Ariga H (2012) One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients. Am J Ophthalmol 154(1):117-124 e1
7. Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, Yoshimura N (2009) Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 29(1):52-59
8. Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R (2007) Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 27(5):589-594
9. von Ruckmann A, Fitzke FW, Bird AC (1997) Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 38(2):478-486
10. von Ruckmann A, Fitzke FW, Bird AC (1997) In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 115(5):609-615
11. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3):718-729
12. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42(5):1051-1056
13. Yamagishi T, Koizumi H, Yamazaki T, Kinoshita S (2012) Fundus autofluorescence in polypoidal choroidal vasculopathy. Ophthalmology 119(8):1650-1657
14. Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U (2011) A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 118(9):1844-1851
15. Otsuji T, Takahashi K, Fukushima I, Uyama M (2000) Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 31(3):210-214
16. Iijima H, Iida T, Imai M, Gohdo T, Tsukahara S (2000) Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 129(1):21-26
17. Ueno C, Gomi F, Sawa M, Nishida K (2012) Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 94(3):297-301
18. Akaza E, Yuzawa M, Mori R (2011) Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 55(1):39-44
19. Kokame GT, Yeung L, Lai JC (2010) Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 94(3):297-301
20. Saito M, Iida T, Kano M (2011) Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Retina 31(8):1589-1597